Smart Biomanufacturing: next-generation biopharma processes
The race for smart biopharma processes is driven by the emergence of three trends: personalized drugs, often tailored the genome of the patient, as a new treatment option for both rare and widespread diseases; flexibility as a means to make plants smarter and adaptable and finally using digitalization to acquire a deep level of process understanding. The industry increasingly relies on small-scale…
![Smart Biomanufacturing in the Pharma Industry smart-manufacturing-pharma-industry](https://assets.new.siemens.com/siemens/assets/api/uuid:357a2588bbcc4ae5a75b9a682bd84fbe9665d90e/width:100/quality:low/crop:0,0:0,13405456255879586:0,9987456883035434:0,8433678269049859/smart-manufacturing-pharma-industry.jpg)
The race for smart biopharma processes is driven by the emergence of three trends: personalized drugs, often tailored the genome of the patient, as a new treatment option for both rare and widespread diseases; flexibility as a means to make plants smarter and adaptable and finally using digitalization to acquire a deep level of process understanding. The industry increasingly relies on small-scale…